These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 12884752)

  • 1. [Direct involvement of the supraspinal phosphoinositide 3-kinase/phospholipase C gamma 1 pathway in the mu-opioid receptor agonist-induced supraspinal antinociception in the mouse].
    Narita M
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2003 Jun; 23(3):121-8. PubMed ID: 12884752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased level of neuronal phosphoinositide 3-kinase gamma by the activation of mu-opioid receptor in the mouse periaqueductal gray matter: further evidence for the implication in morphine-induced antinociception.
    Narita M; Imai S; Narita M; Kasukawa A; Yajima Y; Suzuki T
    Neuroscience; 2004; 124(3):515-21. PubMed ID: 14980723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The involvement of phosphoinositide 3-kinase (PI3-Kinase) and phospholipase C gamma (PLC gamma) pathway in the morphine-induced supraspinal antinociception in the mouse].
    Narita M; Ohnishi O; Nemoto M; Aoki T; Suzuki T
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2001 Feb; 21(1):7-14. PubMed ID: 11400324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pretreatment with pertussis toxin differentially modulates morphine- and beta-endorphin-induced antinociception in the mouse.
    Tseng LF; Collins KA
    J Pharmacol Exp Ther; 1996 Oct; 279(1):39-46. PubMed ID: 8858973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular mechanism of changes in the morphine-induced pharmacological actions under chronic pain-like state: suppression of dopaminergic transmission in the brain.
    Narita M; Suzuki M; Imai S; Narita M; Ozaki S; Kishimoto Y; Oe K; Yajima Y; Yamazaki M; Suzuki T
    Life Sci; 2004 Apr; 74(21):2655-73. PubMed ID: 15041447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RGS14 prevents morphine from internalizing Mu-opioid receptors in periaqueductal gray neurons.
    Rodríguez-Muñoz M; de la Torre-Madrid E; Gaitán G; Sánchez-Blázquez P; Garzón J
    Cell Signal; 2007 Dec; 19(12):2558-71. PubMed ID: 17825524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct evidence for the activation of phospholipase C gamma 1 by in vivo treatment with morphine in the mouse periaqueductal gray matter.
    Narita M; Ohnishi O; Narita M; Aoki T; Suzuki M; Yajima Y; Funahashi H; Shioda S; Suzuki T
    Brain Res; 2003 Apr; 970(1-2):140-8. PubMed ID: 12706255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acetyl-L-carnitine requires phospholipase C-IP3 pathway activation to induce antinociception.
    Galeotti N; Bartolini A; Calvani M; Nicolai R; Ghelardini C
    Neuropharmacology; 2004 Aug; 47(2):286-94. PubMed ID: 15223307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. mu-Opioid receptor internalization-dependent and -independent mechanisms of the development of tolerance to mu-opioid receptor agonists: Comparison between etorphine and morphine.
    Narita M; Suzuki M; Narita M; Niikura K; Nakamura A; Miyatake M; Yajima Y; Suzuki T
    Neuroscience; 2006; 138(2):609-19. PubMed ID: 16417975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic morphine-induced loss of the facilitative interaction between vasoactive intestinal polypeptide and delta-opioid: involvement of protein kinase C and phospholipase Cbetas.
    Liu NJ; Chakrabarti S; Gintzler AR
    Brain Res; 2004 Jun; 1010(1-2):1-9. PubMed ID: 15126111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of supraspinal NMDA receptors by both D-serine alone or in combination with morphine leads to the potentiation of antinociception in tail-flick test of rats.
    Yoshikawa M; Ito K; Maeda M; Akahori K; Takahashi S; Jin XL; Matsuda M; Suzuki T; Oka T; Kobayashi H; Hashimoto A
    Eur J Pharmacol; 2007 Jun; 565(1-3):89-97. PubMed ID: 17383634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basal signaling activity of mu opioid receptor in mouse brain: role in narcotic dependence.
    Wang D; Raehal KM; Lin ET; Lowery JJ; Kieffer BL; Bilsky EJ; Sadée W
    J Pharmacol Exp Ther; 2004 Feb; 308(2):512-20. PubMed ID: 14600246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opioid peptide receptor studies. 17. Attenuation of chronic morphine effects after antisense oligodeoxynucleotide knock-down of RGS9 protein in cells expressing the cloned Mu opioid receptor.
    Xu H; Wang X; Wang J; Rothman RB
    Synapse; 2004 Jun; 52(3):209-17. PubMed ID: 15065220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. H1-receptor stimulation induces hyperalgesia through activation of the phospholipase C-PKC pathway.
    Galeotti N; Malmberg-Aiello P; Bartolini A; Schunack W; Ghelardini C
    Neuropharmacology; 2004 Aug; 47(2):295-303. PubMed ID: 15223308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms involved in phosphatidylinositol 3-kinase pathway mediated up-regulation of the mu opioid receptor in lymphocytes.
    Liu H; Li H; Guo L; Li M; Li C; Wang S; Jiang W; Liu X; McNutt MA; Li G
    Biochem Pharmacol; 2010 Feb; 79(3):516-23. PubMed ID: 19765550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implications of phosphoinositide 3-kinase in the mu- and delta-opioid receptor-mediated supraspinal antinociception in the mouse.
    Narita M; Ohnishi O; Nemoto M; Yajima Y; Suzuki T
    Neuroscience; 2002; 113(3):647-52. PubMed ID: 12150784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential modulation by baclofen on antinociception induced by morphine and beta-endorphin administered intracerebroventricularly in the formalin test.
    Chung KM; Kim YH; Song DK; Huh SO; Suh HW
    Neuropeptides; 1999 Dec; 33(6):534-41. PubMed ID: 10657537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. delta Opioid receptor subtypes activate inositol-signaling pathways in the production of antinociception.
    Sánchez-Blázquez P; Garzón J
    J Pharmacol Exp Ther; 1998 May; 285(2):820-7. PubMed ID: 9580632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of mu opioid receptor desensitization in peripheral sensory neurons by phosphoinositide 3-kinase gamma.
    König C; Gavrilova-Ruch O; von Banchet GS; Bauer R; Grün M; Hirsch E; Rubio I; Schulz S; Heinemann SH; Schaible HG; Wetzker R
    Neuroscience; 2010 Aug; 169(1):449-54. PubMed ID: 20451587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphatidylinositol-3 kinase is distinctively required for mu-, but not kappa-opioid receptor-induced activation of c-Jun N-terminal kinase.
    Kam AY; Chan AS; Wong YH
    J Neurochem; 2004 Apr; 89(2):391-402. PubMed ID: 15056283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.